Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
about
sameAs
The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts.Drf1, a novel regulatory subunit for human Cdc7 kinaseA novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin CPITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitroIsolation and characterization of cytoplasmic cyclin D1 mutantsIdentification of G1 kinase activity for cdk6, a novel cyclin D partnerStimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirusReversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiationGrowth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcriptionThe consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sitesRegulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinaseSpecific regulation of E2F family members by cyclin-dependent kinasesInteraction of D-type cyclins with a novel myb-like transcription factor, DMP1Id2 specifically alters regulation of the cell cycle by tumor suppressor proteinsIn vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expressionDifferent roles for cyclins D1 and E in regulation of the G1-to-S transitionNovel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6Human cyclin E, a nuclear protein essential for the G1-to-S phase transitionSulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cellsAssembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouseMYC and the art of microRNA maintenanceThe structure of CDK4/cyclin D3 has implications for models of CDK activationD-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.Cks1 is required for G(1) cyclin-cyclin-dependent kinase activity in budding yeastTargeting CDK4 and CDK6: From Discovery to Therapycdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domainCyclin D as a therapeutic target in cancerGene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanismIdentification of the p28 subunit of eukaryotic initiation factor 3(eIF3k) as a new interaction partner of cyclin D3Biochemical characterization of p16INK4- and p18-containing complexes in human cell linesPhysical interaction of mammalian CDC37 with CDK4Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localizationA p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanomaCyclin D1: polymorphism, aberrant splicing and cancer risk
P2860
Q22009397-8795235D-A729-46D6-93B8-412DA2538543Q24299753-5077A544-4620-44C2-B863-4F31E54D13CAQ24305321-B5E2C11F-BFA3-475A-B011-06218E831506Q24311956-DBA78AE6-3108-4138-8AEE-9FD271659937Q24312133-D397C5C1-D6F3-4A71-A60F-4D000D5C8CCCQ24320363-47B866FE-67DA-48E4-899C-41276CBCE120Q24324587-6B74E018-0BC3-4482-B0F4-0EDD4615AF78Q24338664-2761F6A1-550B-470B-8AFD-CCAC85BFEFC1Q24537209-B45A6964-3EC4-458D-BCC1-B69B982C3945Q24544755-F0024610-BF55-4921-9DCB-D9663C818ED9Q24553125-36C65021-1DF6-4C69-BDFE-49F9C5D94EADQ24554293-CD8A77DE-CFBB-42B2-B3B8-49D55FE08889Q24561705-1C340F91-1DBB-4DDE-B56C-F8ABA9DCC29BQ24605485-7E36D8FD-048E-4249-A9AB-AB60C5B6F815Q24613134-5734C50D-918E-4EB0-9485-098AA6638614Q24646032-13F8B274-275D-4670-AF24-E19EABE5D739Q24647887-15999A75-CF20-4C29-A355-8ABA6D40DFD4Q24649133-5CBAAA9E-6AD9-4479-AB97-C512D43E6D53Q24650986-E1652951-5955-4927-9D96-8FA49F440BB5Q24651978-93B8F361-D1CA-4E9F-89AF-EFA63DF60DE0Q24652510-8C6BD21D-8FAB-4974-84C8-FE9516A2E11DQ24652527-DCA3E608-AFE3-4D50-877F-DB1B1A64A53EQ24683705-00D55C13-C699-4672-B89E-B975F532E3C7Q24685138-1EA4595B-B7BB-4AEE-9B21-1EF2C26FADF6Q24800908-30CF094A-24AC-40BE-BD38-157DFADF35F7Q26825457-2883E687-DF2E-4168-988C-13EAA9F5CDCFQ27653913-7B8482AC-F2DC-4E6C-BCAC-9F41EC2F3455Q27690967-65A872CC-813C-4F9A-BC3D-D8BBE4EE8BADQ27939842-3DF257C5-48FC-4E08-82EE-C242985BC6D7Q28082912-14CCDA45-92D2-4A96-9EA9-EEF98E147DB4Q28145650-466382FB-5884-49FE-9FAB-064ED51163A3Q28242623-028E16A6-19F6-4D3D-A9A0-DF7DDF2F2E44Q28263590-57706B2C-38FD-4ED9-AF36-9C695572C900Q28278623-313EE514-A7E4-4290-A42B-B5FB7AC69A51Q28281959-C619A662-60B1-4269-98D1-773C7E2E2C07Q28284539-5BC6F232-AA85-4BD1-A202-DB861D576A2EQ28286233-A5F430DB-6618-4BF0-9AD6-9908E37A6009Q28290083-FD8E385C-73D5-4EE1-AFEF-42739C6DE764Q28296086-4948C3D5-8115-4383-BF99-D0D0F058B84BQ28303053-723BA35B-0830-4C72-87E6-9ACE13259AF7
P2860
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Identification and properties ...... or mammalian D type G1 cyclins
@ast
Identification and properties ...... or mammalian D type G1 cyclins
@en
Identification and properties ...... or mammalian D type G1 cyclins
@nl
type
label
Identification and properties ...... or mammalian D type G1 cyclins
@ast
Identification and properties ...... or mammalian D type G1 cyclins
@en
Identification and properties ...... or mammalian D type G1 cyclins
@nl
prefLabel
Identification and properties ...... or mammalian D type G1 cyclins
@ast
Identification and properties ...... or mammalian D type G1 cyclins
@en
Identification and properties ...... or mammalian D type G1 cyclins
@nl
P2093
P3181
P1433
P1476
Identification and properties ...... or mammalian D type G1 cyclins
@en
P2093
H Matsushime
M F Roussel
P304
P3181
P356
10.1016/0092-8674(92)90360-O
P407
P577
1992-10-16T00:00:00Z